Skip to main content

Lake Street Remains a Buy on Achieve Life Sciences (ACHV)

Tipranks - Tipranks - Wed Sep 24, 2025

Lake Street analyst Thomas Flaten reiterated a Buy rating on Achieve Life Sciences today and set a price target of $11.00. The company’s shares closed yesterday at $2.95.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Flaten covers the Healthcare sector, focusing on stocks such as Harrow Health, Insight Molecular Diagnostics, and Achieve Life Sciences. According to TipRanks, Flaten has an average return of 7.5% and a 52.03% success rate on recommended stocks.

Achieve Life Sciences has an analyst consensus of Strong Buy, with a price target consensus of $14.60, implying a 394.92% upside from current levels. In a report released yesterday, H.C. Wainwright also maintained a Buy rating on the stock with a $12.00 price target.

See today’s best-performing stocks on TipRanks >>

ACHV market cap is currently $150.8M and has a P/E ratio of -2.02.

Read More on ACHV:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).